Paper Report for: Hui_1997_J.Chromatogr.B.Biomed.Sci.Appl_695_337
Reference
Title: Development of a sensitive method for quantitation of ABT-089 in plasma using fluorescence labeling with 7-fluoro-4-nitrobenzo-2-oxa-1,3-diazole Hui YH, Carroll S, Marsh KC Ref: Journal of Chromatography B Biomed Sci Appl, 695:337, 1997 : PubMed
A high-performance liquid chromatography method for the quantitation of ABT-089 [2-methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine] (I), a new structural type of cholinergic channel modulators (ChCM), is described in this paper using 7-fluoro-4-nitrobenzo-2-oxa-1,3-diazole (NBD-F) as a fluorescent-labeling reagent. The method combined an optimized liquid-liquid extraction from plasma followed by pre-column derivatization to yield a fluorescence product. The selectivity, sensitivity, and reproducibility of this method were found to be excellent. This method was applied to the determination of ng/ml plasma and tissue levels of ABT-089 and similar compounds in biological samples.
        
Related information
Citations formats
Hui YH, Carroll S, Marsh KC (1997) Development of a sensitive method for quantitation of ABT-089 in plasma using fluorescence labeling with 7-fluoro-4-nitrobenzo-2-oxa-1,3-diazole Journal of Chromatography B Biomed Sci Appl695: 337-47
Hui YH, Carroll S, Marsh KC (1997) Journal of Chromatography B Biomed Sci Appl695: 337-47